Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy: post hoc analysis of the CEREHETIS trial [PDF]
Frontiers in Pharmacology, 2023 Background: There has been intensive research into enhancing the effects of reperfusion therapy to mitigate hemorrhagic transformation (HT) in stroke patients.
Mikhail N. Kalinin +3 more
doaj +2 more sources
Reperfusion therapy of ischemic stroke
Кардиоваскулярная терапия и профилактика, 2020 Aim. To assess the main results of thrombolytic therapy (TLT) in patients with ischemic stroke (IS) in the Regional Vascular Center at the premises of Emergency Hospital in Ufa.Material and methods. A retrospective study of the TLT use was carried out in
L. B. Novikova +3 more
doaj +3 more sources
Intramyocardial Hemorrhage in Patients with Acute Myocardial Infarction Without Reperfusion Therapy: A Prospective Study [PDF]
International Journal of General MedicineMuzheng Li,1 Zhijian Wu,2 Ilyas Tudahun,3 Kun Zhang1 1Department of Cardiology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, People’s Republic of China; 2Department of Pulmonary and Critical Care Medicine, The Second ...
Li M, Wu Z, Tudahun I, Zhang K
doaj +2 more sources
Prevalence and outcomes of mild stroke patients undergoing reperfusion therapy: A meta-analysis and SAFE recommendations for optimal management [PDF]
Journal of Central Nervous System DiseaseBackground Mild acute ischemic stroke (AIS), characterized by a National Institutes of Health Stroke Scale (NIHSS) score of 5 or less, can lead to significant long-term disabilities.
Pathmesh Rajeswaran +4 more
doaj +2 more sources
Reperfusion therapy for ischemic stroke
Неврология, нейропсихиатрия, психосоматика, 2011 .
N. A. Shamalov +3 more
doaj +3 more sources
Biomedicines, 2023 Background: Cerebral microbleeds (CMBs), a notable neuroimaging finding often associated with cerebral microangiopathy, demonstrate a heightened prevalence in patients diagnosed with acute ischemic stroke (AIS), which is in turn linked to less favourable
Shraddha Tipirneni +3 more
doaj +1 more source
Added Value of Rescue Devices in Intra-Arterial Thrombectomy: When Should We Apply Them?
Frontiers in Neurology, 2021 Introduction: Recent trials have demonstrated the superior efficacy of mechanical thrombectomy over other medical treatments for acute ischemic stroke; however, not every large vessel occlusion (LVO) can be recanalized using a single thrombectomy device.
Cheng-Fu Ni +9 more
doaj +1 more source
Time to reperfusion therapy [PDF]
Canadian Medical Association Journal, 2007 [Four of the authors respond:] We thank Jean-Pierre Dery and Robert DeLarochelliere for their comments. Although only 8% of patients who underwent primary percutaneous coronary intervention after interhospital transfer were treated within the recommended time in our study, 36% of those treated ...
T. Huynh +3 more
openaire +3 more sources
Comorbidity index for predicting mortality at 6 months after reperfusion therapy
Scientific Reports, 2021 The eligibility of reperfusion therapy has been expanded to increase the number of patients. However, it remains unclear the reperfusion therapy will be beneficial in stroke patients with various comorbidities.
Hyo Suk Nam +33 more
doaj +1 more source
Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice [PDF]
, 2013 Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH).
Arai, Ken +13 more
core +10 more sources